TR200103149T2 - Virüs ve mikoplazmanın korunması için yöntemler - Google Patents

Virüs ve mikoplazmanın korunması için yöntemler

Info

Publication number
TR200103149T2
TR200103149T2 TR2001/03149T TR200103149T TR200103149T2 TR 200103149 T2 TR200103149 T2 TR 200103149T2 TR 2001/03149 T TR2001/03149 T TR 2001/03149T TR 200103149 T TR200103149 T TR 200103149T TR 200103149 T2 TR200103149 T2 TR 200103149T2
Authority
TR
Turkey
Prior art keywords
virus
protected
mycoplasma
protection
methods
Prior art date
Application number
TR2001/03149T
Other languages
English (en)
Inventor
Edward Worrall Eric
Original Assignee
Edward Worrall Eric
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909999.6A external-priority patent/GB9909999D0/en
Priority claimed from GBGB9926698.3A external-priority patent/GB9926698D0/en
Application filed by Edward Worrall Eric filed Critical Edward Worrall Eric
Publication of TR200103149T2 publication Critical patent/TR200103149T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18451—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Canli bir virüs ya da mikroplazmayi kapsayan biyolojik olarak aktif bir materyel liyofilizasyon olmaksizin, %2'den daha fazla bir kalinti nem içerigine sahip olmayan bir cam gibi trehalos matriksi içerisinde bir kurutma yöntemi tarafindan korunur. Yöntem iki vakum kurutma asamasini kapsar. Tipik bir donma kurutma usülünden çok daha kisa bir döngü zamani içerisinde, bir virüs ya da mitoplazma bir asiya sahip olma potansiyeli vermek için tekrar hidrasyona tabi tutulabilecek bir materyel ortaya koymak için korunabilir.
TR2001/03149T 1999-05-04 2000-05-03 Virüs ve mikoplazmanın korunması için yöntemler TR200103149T2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909999.6A GB9909999D0 (en) 1999-05-04 1999-05-04 Protection of sensitive viruses and bacteria in vaccines
GBGB9926698.3A GB9926698D0 (en) 1999-11-12 1999-11-12 Method for the preserving of viruses, bacteria and biomolecules

Publications (1)

Publication Number Publication Date
TR200103149T2 true TR200103149T2 (tr) 2002-01-21

Family

ID=26315490

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03149T TR200103149T2 (tr) 1999-05-04 2000-05-03 Virüs ve mikoplazmanın korunması için yöntemler

Country Status (18)

Country Link
US (1) US6664099B1 (tr)
EP (1) EP1175486B1 (tr)
JP (1) JP2002542815A (tr)
KR (1) KR100616195B1 (tr)
CN (1) CN1433465A (tr)
AP (1) AP1521A (tr)
AT (1) ATE366797T1 (tr)
AU (1) AU776982B2 (tr)
BR (1) BR0010249A (tr)
CA (1) CA2365277A1 (tr)
DE (1) DE60035497T2 (tr)
DK (1) DK1175486T3 (tr)
EA (1) EA004131B1 (tr)
ES (1) ES2290028T3 (tr)
MX (1) MXPA01011145A (tr)
OA (1) OA11936A (tr)
TR (1) TR200103149T2 (tr)
WO (1) WO2000066710A2 (tr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
RU2418633C2 (ru) 2004-04-08 2011-05-20 Байоматрика, Инк. Объединение процессов хранения образцов и управление образцами в медико-биологических науках
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
DK1973406T3 (da) 2005-12-28 2014-06-23 Advanced Bionutrition Corp Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform
JP5285617B2 (ja) 2006-12-18 2013-09-11 アドバンスド バイオニュートリション コーポレーション 生きたプロバイオティクスを含む乾燥食物製品
SI2144998T1 (sl) 2007-04-06 2017-05-31 Takeda Vaccines, Inc. Postopki in sestavki za žive atenuirane viruse
WO2009012601A1 (en) * 2007-07-26 2009-01-29 Sanofi Pasteur Limited Antigen-adjuvant compositions and methods
DE102007036695A1 (de) * 2007-08-03 2009-02-05 Ab Skf Getriebelageranordnung mit wenigstens einem zweireihigen Schrägkugellager
CA2756883C (en) 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
RU2567668C2 (ru) 2009-05-26 2015-11-10 Эдванст Бионутришн Корпорейшн Стабильная сухая порошкообразная композиция, содержащая биологически активные микроорганизмы и/или биоактивные материалы, и способ ее изготовления
NZ601017A (en) 2010-01-28 2014-07-25 Advanced Bionutrition Corp Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
US9845489B2 (en) 2010-07-26 2017-12-19 Biomatrica, Inc. Compositions for stabilizing DNA, RNA and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
WO2012018638A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
RS57588B1 (sr) 2010-08-13 2018-11-30 Advanced Bionutrition Corp Supstanca za stabilizaciju bioloških materijala za suvo skladištenje
CA2836299A1 (en) 2011-04-15 2012-10-18 Genelux Corporation Clonal strains of attenuated vaccinia viruses and methods of use thereof
WO2014055960A1 (en) 2012-10-05 2014-04-10 Genelux Corporation Energy absorbing-based diagnostic and therapeutic methods employing nucleic acid molecules encoding chromophore-producing enzymes
EP2934572A4 (en) 2012-12-20 2016-11-23 Biomatrica Inc FORMULATIONS AND METHODS FOR STABILIZING PCR REAGENTS
WO2015103438A2 (en) 2014-01-02 2015-07-09 Genelux Corporation Oncolytic virus adjunct therapy with agents that increase virus infectivity
EP3154338B1 (en) 2014-06-10 2020-01-29 Biomatrica, INC. Stabilization of thrombocytes at ambient temperatures
WO2017019273A1 (en) 2015-07-29 2017-02-02 Advanced Bionutrition Corporation Stable dry probiotic compositions for special dietary uses
EP4242628A3 (en) 2015-12-08 2023-11-08 Biomatrica, INC. Reduction of erythrocyte sedimentation rate
CN105462840A (zh) * 2015-12-10 2016-04-06 浙江卫信生物药业有限公司 一种口腔支原体的活体冻干体的制备方法
US20240033347A1 (en) 2022-07-08 2024-02-01 Viromissile, Inc. Oncolytic vaccinia viruses and recombinant viruses and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8801338D0 (en) * 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
GB9125695D0 (en) * 1991-12-03 1992-01-29 Mastavac Limited Medical preparations
ATE239451T1 (de) * 1995-06-07 2003-05-15 Elan Drug Delivery Ltd Verfahren zur stabilen einarbeitung von substanzen in trockene geschäumte glasmatrizen und auf diese weise hergestellte zusammensetzungen
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation

Also Published As

Publication number Publication date
ATE366797T1 (de) 2007-08-15
AP2001002335A0 (en) 2001-12-31
WO2000066710A2 (en) 2000-11-09
EP1175486B1 (en) 2007-07-11
WO2000066710A3 (en) 2001-02-08
ES2290028T3 (es) 2008-02-16
AU4584400A (en) 2000-11-17
DK1175486T3 (da) 2007-10-29
CA2365277A1 (en) 2000-11-09
EP1175486A2 (en) 2002-01-30
DE60035497D1 (de) 2007-08-23
AP1521A (en) 2005-12-22
DE60035497T2 (de) 2007-10-31
KR20020012201A (ko) 2002-02-15
EA004131B1 (ru) 2003-12-25
AU776982B2 (en) 2004-09-30
CN1433465A (zh) 2003-07-30
BR0010249A (pt) 2002-02-13
US6664099B1 (en) 2003-12-16
OA11936A (en) 2006-04-12
MXPA01011145A (es) 2003-07-14
EA200101167A1 (ru) 2002-06-27
JP2002542815A (ja) 2002-12-17
KR100616195B1 (ko) 2006-08-25

Similar Documents

Publication Publication Date Title
TR200103149T2 (tr) Virüs ve mikoplazmanın korunması için yöntemler
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
SE9801288D0 (sv) Vaccine delivery system and metod of production
ES2195866T3 (es) Composiciones acidas multiusos.
ATE290877T1 (de) Stabilisierte insulin-zubereitungen
HUP0000589A2 (hu) Vizes peptid készítmények
DE60119734D1 (de) Hpv-e7 zur behandlung von menschlichem papillomavirus
DK0999853T3 (da) Stabiliseret antostofformulering
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
HRP20020787B1 (en) Method of treatment using ligand-immunogen conjugates
CO5300417A1 (es) Composiciones de polipeptidos toxicas para insectos antonomus, y metodos de uso
HUP0303278A2 (hu) Fagyasztva szárított pantoprazol készítmény, eljárás az előállítására és pantoprazol injekció
DE69727956D1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
ATE125706T1 (de) Diphosphonate enthaltende pharmazeutische zusammensetzungen zur behandlung von arthrosis.
AU2101800A (en) Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
NO953995D0 (no) Ionenolymere som anthelmintica i dyr
WO2002013855A3 (en) Vaccines containing ribavirin and methods of use thereof
SE9904581D0 (sv) A novel helicobacter pylori-binding substance and use thereof
SE0201599D0 (sv) Microparticles
FR2781158B1 (fr) Nouvelles proteines modifiees immunogenes non immunosuppressives, leur procede de preparation et leurs applications
BRPI0416088A (pt) composição, sistema, e método de tratar condições tais como calcificação vascular
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
UY27373A1 (es) Formulaciones de interferón beta-humano
BR9808722A (pt) Composições farmacêuticas de tizoxanida e nitazoxanida
DE60013326D1 (de) Verbindungen und verfahren zur behandlung von schmerz